Serum levels of lipid metabolites in age‐related macular degeneration

Age‐related macular degeneration (AMD) is a neurodegenerative disease that causes adult‐onset blindness. There are 2 forms of this progressive disease: wet and dry. Currently there is no cure for AMD, but several treatment options have started to emerge making early detection critical for therapeutic success. Analysis of the eyes of Abca4‐/‐Rdh8‐/‐ mice that display light‐induced retinal degeneration indicates that 11‐cis‐retinal and docosahexaenoic acid (DHA) levels were significantly decreased as compared with the eyes of control dark‐adapted C57BL/6J mice. In addition, exposure to intense light correlated with higher levels of prostaglandin G2 in the eyes of Abca4‐/‐Rdh8‐/‐ mice. Intense light exposure also lowered DHA levels in the eyes of wild‐type C57BL/6J mice without discernible retinal degeneration. Analysis of human serum from patients with AMD recapitulated these dysregulated DHA levels and revealed dysregulation of arachidonic acid (AA) levels as well (∼32% increase in patients with AMD compared with average levels in healthy individuals). From these observations, we then built a statistical model that included levels of DHA and AA from human serum. This model had a 74% probability of correctly identifying patients with AMD from controls. Addition of a genetic analysis for one of the most prevalent amino acid substitutions in the age‐related maculopathy susceptibility 2 gene linked to AMD, Ala69→Ser, did not improve the statistical model. Thus, we have characterized a reliable method with the potential to detect AMD without a genetic component, paving the way for a larger‐scale clinical evaluation. Our studies on mouse models along with the analysis of human serum suggest that our small molecule‐based model may serve as an effective tool to estimate the risk of developing AMD.—Orban, T., Johnson, W. M., Dong, Z., Maeda, T., Maeda, A, Sakai, T., Tsuneoka, H., Mieyal, J. J., Palczewski, K. Serum levels of lipid metabolites in age‐related macular degeneration. FASEB J. 29, 4579‐4588 (2015). www.fasebj.org

[1]  S. Grisanti,et al.  Serum cytokines as biomarkers for age-related macular degeneration , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  M. Cascella,et al.  Human infrared vision is triggered by two-photon chromophore isomerization , 2014, Proceedings of the National Academy of Sciences.

[3]  J. H. Park,et al.  Identification of vinculin as a potential plasma marker for age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.

[4]  A. Gutchess.  Plasticity of the aging brain: New directions in cognitive neuroscience , 2014, Science.

[5]  U. Lindenberger.  Human cognitive aging: Corriger la fortune? , 2014, Science.

[6]  Meredith A. Shafto,et al.  Language in the aging brain: The network dynamics of cognitive decline and preservation , 2014, Science.

[7]  O. Ates,et al.  Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration , 2014, Clinical ophthalmology.

[8]  F. Ferris,et al.  Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention. , 2014, American journal of ophthalmology.

[9]  Krzysztof Palczewski,et al.  Noninvasive two-photon microscopy imaging of mouse retina and retinal pigment epithelium through the pupil of the eye , 2014, Nature Medicine.

[10]  David R Williams,et al.  Endogenous fluorophores enable two-photon imaging of the primate eye. , 2014, Investigative ophthalmology & visual science.

[11]  J. Deursen.  The role of senescent cells in ageing , 2014, Nature.

[12]  G. R. Jackson,et al.  Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health. , 2014, Investigative ophthalmology & visual science.

[13]  Steffen Schmitz-Valckenberg,et al.  Geographic atrophy: clinical features and potential therapeutic approaches. , 2014, Ophthalmology.

[14]  T. Maeda,et al.  CCL3 Production by Microglial Cells Modulates Disease Severity in Murine Models of Retinal Degeneration , 2014, The Journal of Immunology.

[15]  E. Souied,et al.  Circulating omega-3 Fatty acids and neovascular age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.

[16]  K. Palczewski,et al.  Two-photon microscopy reveals early rod photoreceptor cell damage in light-exposed mutant mice , 2014, Proceedings of the National Academy of Sciences.

[17]  K. Palczewski,et al.  Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. , 2013, The Journal of clinical investigation.

[18]  K. Palczewski,et al.  Retinal degeneration in animal models with a defective visual cycle. , 2013, Drug discovery today. Disease models.

[19]  T. Margrain,et al.  The effect of pre-adapting light intensity on dark adaptation in early age-related macular degeneration , 2013, Documenta Ophthalmologica.

[20]  Alfredo Dubra,et al.  Adaptive Optics Retinal Imaging – Clinical Opportunities and Challenges , 2013, Current eye research.

[21]  M. Miyagi,et al.  Photoreceptor Proteins Initiate Microglial Activation via Toll-like Receptor 4 in Retinal Degeneration Mediated by All-trans-retinal* , 2013, The Journal of Biological Chemistry.

[22]  H. Heimann,et al.  Imaging of retinal and choroidal vascular tumours , 2013, Eye.

[23]  Ralf Tautenhahn,et al.  A view from above: cloud plots to visualize global metabolomic data. , 2013, Analytical chemistry.

[24]  D. Wishart,et al.  Translational biomarker discovery in clinical metabolomics: an introductory tutorial , 2012, Metabolomics.

[25]  A. Vingrys,et al.  Relationship between clinical macular changes and retinal function in age-related macular degeneration. , 2012, Investigative ophthalmology & visual science.

[26]  M. Pennesi,et al.  Animal models of age related macular degeneration. , 2012, Molecular aspects of medicine.

[27]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[28]  Hui Zhao,et al.  The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. , 2012, Investigative ophthalmology & visual science.

[29]  A. Vingrys,et al.  Visual function tests as potential biomarkers in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[30]  K. Palczewski,et al.  Primary amines protect against retinal degeneration in mouse models of retinopathies , 2011, Nature chemical biology.

[31]  G. Superti-Furga,et al.  Complement factor H binds malondialdehyde epitopes and protects from oxidative stress , 2011, Nature.

[32]  Robyn H Guymer,et al.  Identification of urinary biomarkers for age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[33]  C. Luu,et al.  Animal models of retinal disease. , 2011, Progress in molecular biology and translational science.

[34]  David R. Williams,et al.  Images of photoreceptors in living primate eyes using adaptive optics two-photon ophthalmoscopy , 2010, Biomedical optics express.

[35]  Juan Xu,et al.  Three dimensional optical coherence tomography imaging: Advantages and advances , 2010, Progress in Retinal and Eye Research.

[36]  Birgit Grund,et al.  Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves , 2010, Current opinion in HIV and AIDS.

[37]  M. Agbaga,et al.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein , 2010, Journal of Lipid Research.

[38]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[39]  P. Charbel Issa,et al.  In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[40]  K. Palczewski,et al.  Involvement of All-trans-retinal in Acute Light-induced Retinopathy of Mice* , 2009, Journal of Biological Chemistry.

[41]  R. Nagaraj,et al.  Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration* , 2009, Molecular & Cellular Proteomics.

[42]  Sina Farsiu,et al.  Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. , 2009, Ophthalmology.

[43]  D. English,et al.  Adolescents’ use of purpose built shade in secondary schools: cluster randomised controlled trial , 2009, BMJ : British Medical Journal.

[44]  J. Bena,et al.  Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers* , 2009, Molecular & Cellular Proteomics.

[45]  Chi-Chao Chan,et al.  Molecular pathology of age-related macular degeneration , 2009, Progress in Retinal and Eye Research.

[46]  Saskia le Cessie,et al.  Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study , 2009, BMJ : British Medical Journal.

[47]  K. Palczewski,et al.  Retinopathy in Mice Induced by Disrupted All-trans-retinal Clearance* , 2008, Journal of Biological Chemistry.

[48]  Jan Vijg,et al.  Puzzles, promises and a cure for ageing , 2008, Nature.

[49]  Wolfgang Drexler,et al.  State-of-the-art retinal optical coherence tomography , 2008, Progress in Retinal and Eye Research.

[50]  K. Palczewski,et al.  Redundant and unique roles of retinol dehydrogenases in the mouse retina , 2007, Proceedings of the National Academy of Sciences.

[51]  A. Woods,et al.  A Stargardt disease‐3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32–C36 acyl phosphatidylcholines , 2007, FEBS letters.

[52]  Gonçalo R. Abecasis,et al.  A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.

[53]  J. Hoh,et al.  HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration , 2007, Molecular vision.

[54]  Jens Dreyhaupt,et al.  Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. , 2007, American journal of ophthalmology.

[55]  A. Edwards,et al.  Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4 , 2007, Molecular vision.

[56]  Dirk J. Faber,et al.  Recent developments in optical coherence tomography for imaging the retina , 2007, Progress in Retinal and Eye Research.

[57]  Ivana K. Kim,et al.  Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. , 2007, Archives of ophthalmology.

[58]  Maciej Wojtkowski,et al.  Retinal assessment using optical coherence tomography , 2006, Progress in Retinal and Eye Research.

[59]  A. Swaroop,et al.  Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. , 2005, Ophthalmology.

[60]  Lucila Ohno-Machado,et al.  The use of receiver operating characteristic curves in biomedical informatics , 2005, J. Biomed. Informatics.

[61]  R. Wong,et al.  Imaging techniques in retinal research. , 2005, Experimental eye research.

[62]  C. Grimm,et al.  Constitutive Overexpression of Human Erythropoietin Protects the Mouse Retina against Induced But Not Inherited Retinal Degeneration , 2004, The Journal of Neuroscience.

[63]  G. Chader,et al.  Animal models in research on retinal degenerations: past progress and future hope , 2002, Vision Research.

[64]  P. Sieving,et al.  Evaluation of the ELOVL4 gene in patients with age-related macular degeneration , 2001, Ophthalmic genetics.

[65]  C Owsley,et al.  Psychophysical evidence for rod vulnerability in age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[66]  L. Marnett,et al.  Arachidonic Acid Oxygenation by COX-1 and COX-2 , 1999, The Journal of Biological Chemistry.

[67]  G. Martin,et al.  The genetics of aging. , 2003, Annual review of genomics and human genetics.

[68]  L. Guarente,et al.  What Makes Us Tick? , 1997, Science.

[69]  L. Guarente.  Aging. What makes us tick? , 1997, Science.

[70]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[71]  W. Baehr,et al.  Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Fliesler,et al.  Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.

[73]  S. Gelfant,et al.  Aging: Noncycling Cells an Explanation , 1972, Science.